Inspire Trust Co. N.A. Has $5.67 Million Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Inspire Trust Co. N.A. boosted its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 23.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 11,200 shares of the healthcare conglomerate’s stock after purchasing an additional 2,098 shares during the quarter. UnitedHealth Group comprises approximately 1.4% of Inspire Trust Co. N.A.’s investment portfolio, making the stock its 15th biggest position. Inspire Trust Co. N.A.’s holdings in UnitedHealth Group were worth $5,666,000 as of its most recent SEC filing.

Several other large investors also recently modified their holdings of the stock. Norges Bank acquired a new position in shares of UnitedHealth Group in the fourth quarter valued at about $6,375,744,000. Raymond James Financial Inc. acquired a new position in shares of UnitedHealth Group during the 4th quarter worth approximately $1,914,740,000. Amundi raised its position in shares of UnitedHealth Group by 97.2% in the fourth quarter. Amundi now owns 6,069,100 shares of the healthcare conglomerate’s stock valued at $3,183,132,000 after buying an additional 2,991,470 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its position in UnitedHealth Group by 36.6% during the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 8,592,718 shares of the healthcare conglomerate’s stock worth $4,346,712,000 after buying an additional 2,301,010 shares in the last quarter. Finally, Proficio Capital Partners LLC raised its holdings in UnitedHealth Group by 76,830.4% in the 4th quarter. Proficio Capital Partners LLC now owns 1,888,641 shares of the healthcare conglomerate’s stock valued at $955,388,000 after acquiring an additional 1,886,186 shares in the last quarter. 87.86% of the stock is owned by institutional investors.

Insider Transactions at UnitedHealth Group

In other UnitedHealth Group news, Director Timothy Patrick Flynn acquired 1,533 shares of the company’s stock in a transaction dated Wednesday, May 14th. The shares were bought at an average cost of $320.80 per share, with a total value of $491,786.40. Following the purchase, the director now directly owns 6,033 shares of the company’s stock, valued at $1,935,386.40. This trade represents a 34.07% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Stephen J. Hemsley bought 86,700 shares of the firm’s stock in a transaction that occurred on Friday, May 16th. The shares were acquired at an average cost of $288.57 per share, with a total value of $25,019,019.00. Following the purchase, the chief executive officer now directly owns 679,493 shares of the company’s stock, valued at $196,081,295.01. This trade represents a 14.63% increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last 90 days, insiders have bought 109,408 shares of company stock worth $31,607,768. Company insiders own 0.33% of the company’s stock.

UnitedHealth Group Stock Down 5.8%

NYSE:UNH opened at $303.08 on Thursday. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. UnitedHealth Group Incorporated has a one year low of $248.88 and a one year high of $630.73. The firm’s 50 day simple moving average is $460.62 and its 200 day simple moving average is $508.74. The company has a market cap of $274.93 billion, a PE ratio of 19.55, a P/E/G ratio of 1.37 and a beta of 0.56.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing analysts’ consensus estimates of $7.29 by ($0.09). The company had revenue of $109.58 billion during the quarter, compared to analyst estimates of $111.56 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. During the same quarter in the previous year, the company earned $6.91 earnings per share. On average, research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were given a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a yield of 2.77%. The ex-dividend date was Monday, March 10th. UnitedHealth Group’s dividend payout ratio is presently 35.18%.

Analyst Upgrades and Downgrades

UNH has been the subject of a number of analyst reports. Wolfe Research dropped their price target on UnitedHealth Group from $501.00 to $390.00 and set an “outperform” rating for the company in a research note on Tuesday. Wells Fargo & Company dropped their target price on shares of UnitedHealth Group from $677.00 to $351.00 and set an “overweight” rating for the company in a research report on Wednesday, May 14th. Morgan Stanley decreased their price objective on shares of UnitedHealth Group from $563.00 to $374.00 and set an “overweight” rating on the stock in a research note on Wednesday, May 14th. Deutsche Bank Aktiengesellschaft cut their target price on UnitedHealth Group from $521.00 to $362.00 and set a “buy” rating for the company in a research note on Wednesday, May 14th. Finally, TD Cowen cut UnitedHealth Group from a “buy” rating to a “hold” rating and set a $308.00 price target for the company. in a report on Monday. One investment analyst has rated the stock with a sell rating, seven have issued a hold rating, eighteen have issued a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $441.87.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.